|
| Human APLP2 Protein (LTP10160) |
|
| LTP10160 |
|
| 100ug |
|
|
$383 In stock |
| Amyloid ? precursor-like protein 2 (APLP2) has been determined to serve an important role in the progression of a number of cancer types. APLP2 expression was significantly associated with disease-specific survival (P<0.001). APLP2 may be used to potentially predict patient prognosis, and to guide clinical diagnosis and treatment in CCRCC. |
| Recombinant Human APLP2 Protein is expressed from Expi293 with His tag at the C-terminal. It contains Gly32-Ser692. |
|
| APLP2 |
|
| Human |
|
| Q06481-1 |
|
| Gly32-Ser692 |
|
| The protein has a predicted MW of 77.16 kDa. Due to glycosylation, the protein migrates to 85-100 kDa based on the Tris-Bis PAGE result. |
|
| 0 |
|
| C-His |
|
| Expi293 |
|
| > 95% as determined by Tris-Bis PAGE; > 95% as determined by HPLC |
|
| Less than 1EU per ug by the LAL method. |
|
| Lyophilized from 0.22 um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as a protectant before lyophilization. |
|
| Reconstituted protein stable at -80 C for 12 months, 4 C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
|
| Shipped at ambient temperature. |
|
| Centrifuge tubes before opening. Reconstituting to a concentration of more than 100 ug/ml is recommended. Dissolve the lyophilized protein in distilled water. |
|
|  |
